Ally Financial (ALLY)

NYSEFinancialsFinancial - Credit ServicesSnapshot 2026-10-23

$39.06-0.64%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Ally Financial’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

-5.8%

+10% or more+5%0%−5%−10% or less

6.39 → 6.02 EPS · FY ending Dec 31, 2027 · 11 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 12 to 11; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	2.35B
EPS	—	1.358
Quarter ending 2027-03-31
Revenue	—	2.34B
EPS	—	1.404
Annual ending 2026-12-31
Revenue	—	9.09B
EPS	—	4.993
Annual ending 2027-12-31
Revenue	—	9.61B
EPS	—	6.018

Management figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Cash from operating activities at least $1.37 billion in 2026-Q1	Cash from operations rose to $1.37 billion in 2026-Q1.	Intact	Cash from operations falls below $1.37 billion in 2026-Q1	Cash from operations: $675M FY2026-Q2; GAAP. Published target: >= $1.37 billion. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Source published Jul 23, 2026675,000,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Maintain consistent dividend payout	A supporting condition in Ally Financial's published investment case. The stated target is Maintain current dividend payout policy.	Intact	Dividend payout is cut or inconsistent	Dividend raised in Q3 2026 Ally Financial Q3 2026 slides report turnaround gains and a dividend raise. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Net income at least $319 million in 2026-Q1	A supporting condition in Ally Financial's published investment case. The stated target is >= $319 million.	Under Pressure	Net income falls below $319 million in 2026-Q1	Net income: $410M FY2026-Q2; GAAP. Published target: >= $319 million. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Source published Jul 23, 2026410,000,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 346e9f02-aa09-4ea4-ac16-16521278e798. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Revenue at least $7.9 billion in 2025	A primary condition in Ally Financial's published investment case. The stated target is >= $7.9 billion.	Intact	Revenue falls below $7.9 billion in FY25	Revenue: $2.286B FY2026-Q2; GAAP. Published target: >= $7.9 billion. Target period is not explicitly aligned with this observation. Source published Jul 23, 20262,286,000,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 346e9f02-aa09-4ea4-ac16-16521278e798. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$6.02

$6.44 → $6.02 · observed estimates

FY2027 revenue$9.61B

$9.59B → $9.61B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$6.44	$9,591,146,690	15 / 16
2026-07-25	$6.43	$9,602,112,280	16 / 16
2026-07-26	$6.43	$9,602,112,280	16 / 16
2026-07-27	$6.43	$9,602,112,280	16 / 16
2026-07-28	$6.43	$9,602,112,280	16 / 16
2026-07-29	$6.44	$9,606,616,650	16 / 16
2026-07-30	$6.44	$9,606,616,650	16 / 16
2026-07-31	$6.44	$9,606,616,650	16 / 16
2026-08-01	$6.44	$9,606,616,650	16 / 16
2026-08-02	$6.44	$9,606,616,650	16 / 16
2026-08-03	$6.44	$9,606,616,650	16 / 16
2026-08-04	$6.44	$9,606,616,650	16 / 16
2026-08-05	$6.44	$9,606,616,650	16 / 16
2026-08-06	$6.43	$9,616,530,810	16 / 16
2026-08-07	$6.42	$9,652,584,542	11 / 11
2026-08-08	$6.43	$9,616,530,810	16 / 16
2026-08-09	$6.43	$9,616,530,810	16 / 16
2026-08-10	$6.43	$9,616,530,810	16 / 16
2026-08-11	$6.42	$9,652,584,542	11 / 11
2026-08-12	$6.43	$9,616,530,810	16 / 16
2026-08-13	$6.43	$9,616,530,810	16 / 16
2026-08-14	$6.42	$9,652,584,542	11 / 11
2026-08-15	$6.42	$9,652,584,542	11 / 11
2026-08-16	$6.42	$9,652,584,542	11 / 11
2026-08-17	$6.42	$9,652,584,542	11 / 11
2026-08-18	$6.42	$9,652,584,542	11 / 11
2026-08-19	$6.42	$9,652,584,542	11 / 11
2026-08-20	$6.41	$9,664,291,621	11 / 12
2026-08-21	$6.41	$9,664,291,621	11 / 12
2026-08-22	$6.41	$9,664,291,621	11 / 12
2026-08-23	$6.41	$9,664,291,621	11 / 12
2026-08-24	$6.41	$9,664,291,621	11 / 12
2026-08-25	$6.41	$9,664,291,621	11 / 12
2026-08-26	$6.41	$9,664,291,621	11 / 12
2026-08-27	$6.41	$9,664,291,621	11 / 12
2026-08-28	$6.41	$9,664,291,621	11 / 12
2026-08-29	$6.41	$9,664,290,051	11 / 12
2026-08-30	$6.41	$9,664,290,051	11 / 12
2026-08-31	$6.41	$9,664,290,051	11 / 12
2026-09-01	$6.41	$9,664,290,051	11 / 12
2026-09-02	$6.42	$9,667,735,036	11 / 12
2026-09-03	$6.42	$9,667,734,423	12 / 12
2026-09-04	$6.42	$9,667,734,423	12 / 13
2026-09-05	$6.42	$9,667,734,423	12 / 12
2026-09-06	$6.42	$9,667,734,423	12 / 12
2026-09-07	$6.42	$9,667,734,423	12 / 12
2026-09-08	$6.42	$9,667,734,423	12 / 12
2026-09-09	$6.42	$9,667,734,423	12 / 12
2026-09-10	$6.42	$9,667,734,423	12 / 12
2026-09-11	$6.42	$9,667,734,423	12 / 12
2026-09-12	$6.42	$9,667,734,423	12 / 12
2026-09-13	$6.42	$9,667,734,423	12 / 12
2026-09-14	$6.42	$9,667,734,423	12 / 12
2026-09-15	$6.42	$9,667,734,423	12 / 12
2026-09-16	$6.42	$9,667,734,423	12 / 12
2026-09-17	$6.42	$9,667,734,423	12 / 12
2026-09-18	$6.42	$9,667,734,423	12 / 12
2026-09-19	$6.42	$9,667,734,423	12 / 12
2026-09-20	$6.42	$9,667,734,423	12 / 12
2026-09-21	$6.42	$9,667,734,423	12 / 12
2026-09-22	$6.39	$9,651,116,718	12 / 12
2026-09-23	$6.39	$9,652,250,051	12 / 12
2026-09-24	$6.39	$9,652,250,051	12 / 12
2026-09-25	$6.39	$9,652,250,051	12 / 12
2026-09-26	$6.39	$9,642,516,991	12 / 12
2026-09-27	$6.39	$9,642,516,991	12 / 12
2026-09-28	$6.39	$9,642,516,991	12 / 12
2026-09-29	$6.39	$9,642,516,991	12 / 12
2026-09-30	$6.39	$9,642,516,991	12 / 12
2026-10-01	$6.34	$9,631,866,822	11 / 12
2026-10-02	$6.34	$9,631,666,822	11 / 12
2026-10-03	$6.34	$9,631,666,822	11 / 12
2026-10-04	$6.34	$9,631,666,822	11 / 12
2026-10-05	$6.34	$9,631,666,822	11 / 12
2026-10-06	$6.26	$9,611,272,708	11 / 12
2026-10-07	$6.23	$9,605,491,054	11 / 12
2026-10-08	$6.18	$9,593,877,797	11 / 12
2026-10-09	$6.18	$9,593,877,797	11 / 12
2026-10-10	$6.18	$9,593,877,797	11 / 12
2026-10-11	$6.18	$9,591,457,797	11 / 12
2026-10-12	$6.18	$9,591,457,797	11 / 12
2026-10-13	$6.12	$9,580,277,750	11 / 12
2026-10-14	$6.12	$9,580,277,750	11 / 12
2026-10-15	$6.12	$9,580,277,750	11 / 12
2026-10-16	$6.12	$9,580,277,750	11 / 12
2026-10-17	$6.12	$9,580,277,750	11 / 12
2026-10-18	$6.12	$9,580,277,750	11 / 12
2026-10-19	$6.12	$9,580,277,750	11 / 12
2026-10-20	$6.12	$9,580,277,750	11 / 12
2026-10-21	$6.09	$9,606,828,842	11 / 12
2026-10-22	$6.09	$9,606,828,842	11 / 12
2026-10-23	$6.03	$9,606,244,699	11 / 12
2026-10-24	$6.02	$9,606,334,846	11 / 12

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	14	4
2026-06-01	14	4
2026-07-01	14	4
2026-08-01	14	4
2026-09-01	16	4
2026-10-01	15	5

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 15 Buy / Strong Buy · 5 Hold · 0 Sell / Strong Sell

0 upgrades3 downgrades9 maintains

Recent actions · Sep 25–Oct 24 · 12 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Evercore ISIOct 21

$40.00New observation · no comparable prior

Deutsche BankOct 21 · prior Jul 22

$58.00 → $56.00-3.4%

Morgan StanleyOct 12

$43.00New observation · no comparable prior

RBC CapitalOct 9 · prior Jul 10

$55.00 → $50.00-9.1%

Raymond JamesOct 6 · prior Sep 1

$55.00 → $52.00-5.5%

Goldman SachsOct 6 · prior Apr 20

$56.00 → $45.00-19.6%

UBSOct 5

$50.00New observation · no comparable prior

Wells FargoSep 30 · prior Jun 26

$55.00 → $42.00-23.6%

$0$31.90$63.80

0 raises · 5 cuts · 0 unchanged · 3 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Cash from operating activities at least $1.37 billion in 2026-Q1Cash from operations: $675M
Net income at least $319 million in 2026-Q1Published status: Under Pressure
Revenue at least $7.9 billion in 2025Revenue: $2.286B

Next proof point

Next earnings date unavailable

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.0%Typical daily move · historical

Downside history

-23.0%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Ally Financial outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

ALLY is a financial company with a meaningful consumer auto lending business, so this is a value-oriented, cyclical long-term thesis rather than a uniformly steady growth story. The thesis is intact this month, but execution is mixed across its stated priorities.

What's priced into Ally Financial

The valuation evidence describes ALLY as cheap versus peers, with a negative expectations gap, meaning expectations appear relatively restrained. Pricing is tagged as justified, and the evidence shows low fragility, though valuation has risen recently.

What the fundamentals likely do

Recent performance is strong, including an earnings beat on October 20, while revenue and consumer auto originations grew between the compared quarters. Returns were lower, deposits were nearly unchanged, and the July earnings miss remains a reminder of near-term execution risk; the supplied miss-risk estimate is low.

What Ally Financial hinges on

The multi-year thesis depends on growing core franchises while improving returns, sustaining customer and deposit growth, and keeping credit disciplined. Near term, a guidance cut or rate cuts would be adverse risks, while continued strength from financial-sector bellwethers could support sector momentum.